Tag Archives: Phase III

GSK’s mRNA Flu Vaccine Candidate Moves to Phase III After Positive Phase II Results

(IN BRIEF) GSK has reported positive results from its phase II trial for an mRNA seasonal influenza vaccine candidate, showing strong immune responses against influenza A and B strains in both younger and older adults. The trial met success criteria … Read the full press release